{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:16Z","timestamp":1761059236270},"publisher-location":"Berlin, Heidelberg","reference-count":34,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642640384"},{"type":"electronic","value":"9783642595875"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000]]},"DOI":"10.1007\/978-3-642-59587-5_2","type":"book-chapter","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T15:09:26Z","timestamp":1315321766000},"page":"15-22","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Endocrine Gastroenteropancreatic Tumors with Somatostatin Analogues"],"prefix":"10.1007","author":[{"given":"H.-C.","family":"Fehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Wulbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","first-page":"431","volume-title":"Endocrine tumors of the pancreas","author":"R Arnold","year":"1995","unstructured":"Arnold R, Frank M (1995) Systemic chemotherapy for endocrine tumors of the pancreas: recent advances. In: Mignon M, Jensen RT (eds) Endocrine tumors of the pancreas. Karger, Basel, pp 431\u2013438"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0950-3528(96)90021-4","volume":"10","author":"R Arnold","year":"1996","unstructured":"Arnold R, Frank M (1996) Gastrointestinal endocrine tumors: medical management. Baillieres Clin Gastroenterol 10:737\u2013759","journal-title":"Baillieres Clin Gastroenterol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF01655111","volume":"17","author":"R Arnold","year":"1993","unstructured":"Arnold R, Neuhaus C, Benning R, Schwerk WB, Trautmann ME, Joseph K, Bruns C (1993) Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors. World J Surg 17: 511\u2013519","journal-title":"World J Surg"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gut.38.3.430","volume":"38","author":"R Arnold","year":"1996","unstructured":"Arnold R, Trautmann ME, Creutzfeldt W, Benning R, Benning M, Neuhaus C, J\u00fcrgensen R, Stein K, Sch\u00e4fer H, Bruns C, Dennler HJ (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38: 430\u2013438","journal-title":"Gut"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0889-8553(21)00444-1","volume":"18","author":"G Boden","year":"1989","unstructured":"Boden G (1989) Glucagonomas and insulinomas. Gastrenterol Clin North Am 18:831\u2013847","journal-title":"Gastrenterol Clin North"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM198606263142606","volume":"314","author":"G Boden","year":"1989","unstructured":"Boden G, Ryan IG, Eisenschmidt BL, Shelmet JJ, Owen OE (1986) Treatment of inoperable glucagonoma with long-acting somatostatin analogue SMS 201\u2013995. N Engl J Med 314: 1686\u20131689","journal-title":"N Engl J Med"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.179.4068.77","volume":"179","author":"P Brazeau","year":"1973","unstructured":"Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guilleman R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77\u201379","journal-title":"Science"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0140-6736(85)92235-4","volume":"1","author":"D Clements","year":"1985","unstructured":"Clements D, Elias E (1985) Regression of metastatic VIPoma with somatostatin analogue SMS 201\u2013995. Lancet 1:874\u2013875","journal-title":"Lancet"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/381242a0","volume":"381","author":"L Lecea de","year":"1996","unstructured":"de Lecea L, Criado JR, Propero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CLM, Siggins GR, Nenrksen SJ, Sutcliffe JG (1996) A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381: 242\u2013245","journal-title":"Nature"},{"key":"2_CR10","first-page":"767","volume":"34","author":"HC Fehmann","year":"1996","unstructured":"Fehmann HC; Arnold R (1996) Molekularbiologie, Pharmakologie uns Signal transduktion der f\u00fcnf klonierten humanen Somatostatin Rezeptoren1. Z Gastroenterol 34:767\u2013774","journal-title":"Z Gastroentero"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0950-3528(96)90019-6","volume":"10","author":"S Frankton","year":"1996","unstructured":"Frankton S, Bloom SR (1996) Glucagonomas. Baillieres Clin Gastroenterol 10:697\u2013705","journal-title":"Baillieres Clin Gastroenterol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/bbrc.1997.6252","volume":"232","author":"S Fukusumi","year":"1997","unstructured":"Fukusumi S, Kitada C, Takekawa S, Sakamoto M, Miyamoto M Hinuma S, KItano K, Fujino M (1997) Identification and characterization of a novel human cortistatin-like peptide. Biochem Biophys Res Commun 232: 157\u2013163","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2036.1995.tb00396.x","volume":"9","author":"AG Harris","year":"1995","unstructured":"Harris AG, Redfern JS (1995) Octreotide treatment of carcinoid syndrome: analysis of published dose-titration data. Aliment Pharmacol Ther 9: 387\u2013394","journal-title":"Aliment Pharmacol Ther"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1365-2362.1997.1740719.x","volume":"27","author":"P Jais","year":"1997","unstructured":"Jais P, Terris B, Ruszniewski P, Le Romancer M, Reyl-Desmars F, Vlssuzaine C, Cadiot G, Mignon M, Lewin MJM (1997) Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. Eur J Clin Invest 27:639\u2013644","journal-title":"Eur J Clin Invest"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/gut.38.1.33","volume":"38","author":"M John","year":"1996","unstructured":"John M, Meyerhof W, Richter D (1996) Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 38: 33\u201339","journal-title":"Gut"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF00186414","volume":"380","author":"S Jonas","year":"1995","unstructured":"Jonas S, John M, Boese-Landgraf J (1995) Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues. Langenbecks Arch Chir 380: 90\u201395","journal-title":"Langenbecks Arch Chir"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI117090","volume":"93","author":"A Kubota","year":"1995","unstructured":"Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M Tsuda K, Imura H, Seine S, Seino Y (1995) Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201\u2013995 in treatment of human endocrine tumors. J Clin Invest 93: 1321\u20131325","journal-title":"J Clin Invest"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1056\/NEJM199601253340408","volume":"334","author":"SWJ Lamberts","year":"1996","unstructured":"Lamberts SWJ, Lely AJ, Herder WW, Hofland L (1996) Octreotide. N Engl J Med 334:246\u2013254","journal-title":"N Engl J Med"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1073\/pnas.81.11.3337","volume":"81","author":"MR Montminy","year":"1984","unstructured":"Montminy MR, Goodman RH, Horovitch SJ, Habener JF (1984) Primary structure of the gene encoding rat prosomatostatin. Proc Natl Acad Sci USA 81:3337\u20133340","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1210\/en.135.6.2814","volume":"135","author":"Y Patel","year":"1995","unstructured":"Patel Y, Srikant CB (1995) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hSSTRl-5). Endocrinology 135:2814\u20132817","journal-title":"Endocrinology"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1210\/me.11.8.1062","volume":"11","author":"DB Reardon","year":"1997","unstructured":"Reardon DB, Dent P, Wood SL, Kong T, Sturgill TW (1997) Activation in vitro of somatostatin receptor subtypes 2, 3 or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected ras transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol 11: 1062\u20131069","journal-title":"Mol Endocrinol"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1210\/jcem-65-6-1127","volume":"65","author":"JC Reubi","year":"1987","unstructured":"Reubi JC, H\u00e4cki W, Lamberts SWJ (1987) Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 65: 1127\u20131134","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR23","first-page":"3455","volume":"54","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Schaer JC, Waser B, Mengod G (1994) Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 mRNAs in primary human tumors using in situ hybridization. Cancer Res 54: 3455\u20133459","journal-title":"Cancer Res"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/gut.39.2.279","volume":"39","author":"P Ruszniewski","year":"1996","unstructured":"Ruszniewski P, Ducreux M, Chayvialle JA (1996) Treatment of carcinoid syndrome with the long-acting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 39: 279\u2013283","journal-title":"Gut"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q","volume":"72","author":"L Saltz","year":"1993","unstructured":"Saltz L, Trochanowsky G, Buckley M, Heffernan B, Niedzwicki D, Tao Y, Kelsen D (1993) Octreotide as an anti-neoplastic agent in the treatment of functional and non-functional neuroendocrine tumours. Cancer 72: 244\u2013248","journal-title":"Cancer"},{"key":"2_CR26","first-page":"385","volume-title":"Endocrine tumors of the pancreas","author":"C Scarpignato","year":"1995","unstructured":"Scarpignato C (1995) Somatostatin analogues in the management of endocrine tumors of the pancreas. In: Mignon M, Jensen RT (eds) Endocrine tumors of the pancreas. Karger, Basel, pp 385\u2013414"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<530::AID-IJC7>3.0.CO;2-Z","volume":"70","author":"JC Schaer","year":"1997","unstructured":"Schaer JC, Waser B, Mengod G, Reubi JC (1997) Somatostatin receptor subtypes sstl, sst2, sst3, sst4, sst5 expression in human pituitary, gastroenteropancreatic and mammary tumors: comparison of MRNA analysis with receptor autoradiography. Int J Cancer 70: 530\u2013537","journal-title":"Int J Cancer"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/me.10.12.1688","volume":"10","author":"K Sharma","year":"1996","unstructured":"Sharma K, Patel YC, Srikant CB (1996) Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10: 1688\u20131696","journal-title":"Mol Endocrinol"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0140-6736(86)90139-X","volume":"2","author":"JJ Shepherd","year":"1986","unstructured":"Shepherd JJ, Senator GB (1986) Regression of liver metastases in patient with gastrin-secreting tumour treated with SMS 201\u2013995. Lancet 2: 574","journal-title":"Lancet"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1006\/bbrc.1994.1547","volume":"200","author":"H Tomura","year":"1994","unstructured":"Tomura H, Okajima F, Akbar M, Abdul-Majid M, Sho K, Kondo Y (1994) Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2+ mobilization. Biochem Biophys Res Commun 200:986\u2013992","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1210\/jc.80.10.2974","volume":"80","author":"S Vikic-Topic","year":"1995","unstructured":"Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S (1995) Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumors and renal cell carcinoma. J Clin Endocrinol Metab 80: 2974\u20132979","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01713015","volume":"66","author":"B Wiedenmann","year":"1988","unstructured":"Wiedenmann B, Rath U, Radsch R, Becker F, Kommereil B (1988) Tumour regression of an ileal carcinoid under treatment with the somatostatin analogue SMS 201\u2013995. Klin Wochenschr 66: 75\u201377","journal-title":"Klin Wochenschr"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1046\/j.1365-2362.1998.00397.x","volume":"28","author":"U Wulbrand","year":"1998","unstructured":"Wulbrand U, Wied M, Zofel P, Goke B, Arnold R, Fehmann HC (1998) Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours. Eur J Clin Invest 28: 1038\u20131049","journal-title":"Eur J Clin Invest"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"10836","DOI":"10.1073\/pnas.95.18.10836","volume":"95","author":"L Yang","year":"1998","unstructured":"Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L et al (1998] Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA 95:10836","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Recent Results in Cancer Research","Peptides in Oncology III"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-59587-5_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T08:07:50Z","timestamp":1638518870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-59587-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"ISBN":["9783642640384","9783642595875"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-59587-5_2","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[2000]]}}}